Statistics for Anixa Biosciences (id:5526 ANIX)

Valuation metrics

Market cap

98.15M

Enterprise value

77.52M

Trailing P/E (ttm)

-10.00

Forward P/E

-8.47

PEG ratio

-8.47

Price/Sales (ttm)

467.37

Price/Book (mrq)

4.51

Enterprise Value/Revenue

369.17

Enterprise Value/EBITDA

-7.07

Overview

Shares outstanding

32.18M

Float

30.55M

Shares short

421.92K

% Held by insiders

0.05%

% Held by institutions

0.17%

Average volume (10 days)

128.62K

Average volume (90 days)

Price summary

52-Week low

2.15

52-Week high

5.13

52-Week change

7.50%

Beta

0.85

50-Day moving average

3.26

200-Day moving average

3.16

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

October 18th, 2016

Financials

Fiscal year

Fiscal year ends

October 31th, 2023

Most recent quarter (mrq)

July 31th, 2024

Profitability

Profit margin

23.33%

Operating margin

-5,243.33%

Operational effectiveness

Return on assets

-34.65%

Return on equity

-55.24%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

49.00K

EBITDA

0.00

Net income to common (ttm)

-12,361,000.00

Diluted EPS (ttm)

-0.39

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

20.74M

Total cash per share (mrq)

0.64

Total debt (mrq)

237.00K

Total Debt/Equity (mrq)

1.14

Current ratio (mrq)

1.13K%

Book value per share (mrq)

0.68

Cash flow

Cash flow statement

-8,377,000.00

Levered free cash flow (LFCF)

-4,303,375.00